Dermatology Times Staff

Image IQ:  A man presents to his doctor with hand numbness, pain, skin tightness and raised scars. What’s your diagnosis?

Investigators from the Health Hazard Evaluation Program of the Centers for Disease Control and Prevention recently issued these safety recommendations for tattoo removal.

Zoe Diana Draelos, M.D., clinical and research dermatologist, offers guidance on several cosmetic issues. View our slideshow of the top 8 Cosmetic Conundrums from 2018.

Image IQ: A 52-year-old man undergoing chemotherapy experiences erythematous lesions on his palms and soles five days after treatment. What’s your diagnosis?

The Food and Drug Administration (FDA) approved sarecycline (Seysara, Almirall, S.A.) in October for the treatment of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older, according to a company news release.

Victor Desmond Mandel, M.D. and colleagues describe a reconstruction strategy for chronic infected neoplastic ulcers of the lower extremities using a dermal matrix and a unique postoperative dressing protocol.

Image IQ: A 55-year-old woman with a history of inflammatory bowel disease reported a very painful, deep pustule on her leg that may rupture. What’s your diagnosis?

Widespread rashes, red perpendicular lines and mysterious deep pustules are among the skin manifestations we feature in this collection of image IQs.

The American Academy of Dermatology has updated its guidelines for the care and management of primary cutaneous melanoma. The guidelines, which were released this week, cover the treatment of primary cutaneous melanoma for all age groups.

Image IQ:  A 43-year-old man with a symmetrical palpable purpura rash on his legs. What’s your diagnosis?

A 10-year-old girl is experiencing hair loss with no signs of lesions or scarring on her scalp. What’s your diagnosis?

Gender and sex play a part in detemining which topical products are most successful for patients. This table is compiled based on a review of articles form the International Journal of Women's Dermatology.

Pruritic skin lesions on the foot and lower leg that look like red lines in a serpiginous configuration. What’s your diagnosis?

A nodule develops over the course of months with pain, swelling, distal numbness and muscle weakness. What’s your diagnosis?

AIVITA Biomedical, a biotech firm that focuses on regenerative medicines such as stem cell applications, recently named two new members to its senior management team.

Two dermatology practices join forces to deliver excellent treatment options to patients in El Paso, Texas.

The FDA has approved Ortho Dermatologic’s new drug application for Altreno (tretinoin 0.05 percent) lotion for the treatment of acne vulgaris.

Two dermatology firms combine to improve their medical and cosmetic dermatology services, existing treatments and procedures.

Kleresca's new biophotonic technology received CE mark of approval, which will allow it to expand in the U.S., Canada, Australia and throughout Europe.

Multiple burning, painful skin lesions appear on the legs the morning after a walk in the woods. What’s your diagnosis?

An 18-year-old girl with small widespread, itchy brown macules primarily on her trunk. What’s your diagnosis?

Effective therapeutic protocols for acne scarring should consider the multifacted aspects of scarring, such as erythema (redness), signs of bacterial infection, signs of atrophic scars and whether the scars are generalized or individualized.

In this slideshow, we highlight some of the most innovative and important clinical advances in the treatment of atopic dermatitis.

The FDA is exploring ways to prevent long-term drug shortages and allow more drug importation so patients have access to medically necessary drugs.

Physicians throughout the country are recruiting patients for two phase three clinical trials of cantharidin for the treatment of molluscum contagiousum. a viral skin condition.

Ortho Dermatologics announced in August that it resubmitted a new drug application to the FDA for DUOBRIITM1, a lotion for the treatment of plaque psoriasis.

PharmaTimes reported in August that the Spanish company Almirall acquired Allergan’s U.S. dermatology portfolio for $650 million.